Xia, Y., Cai, Q., Huang, H., Chen, N., Jiang, J., Ying, Z., Zheng, R., Liu, J., Jiang, Y., Wang, L., Fang, X., Nie, M., Gao, Y., Wang, X., Zhang, Y., Cai, J., Cao, Y. (2026). Zanubrutinib plus rituximab as front-line treatment for mucosa-associated lymphoid tissue (MALT) lymphoma: A single-arm, phase II study (ZAMA).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7080